Xiaozhao Wang

Person

Drexel Hill, PA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Hetero-bicyclic inhibitors of KRAS
- Patent number 12,331,063
- Issue date Jun 17, 2025
- Incyte Corporation
- Alexander Sokolsky
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazole and triazole KRAS inhibitors
- Patent number 12,077,539
- Issue date Sep 3, 2024
- Incyte Corporation
- Chao Qi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...
- Patent number 12,060,433
- Issue date Aug 13, 2024
- Incyte Corporation
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hetero-tricyclic compounds as inhibitors of KRAS
- Patent number 12,030,883
- Issue date Jul 9, 2024
- Incyte Corporation
- Peter Carlsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazoloquinoline KRAS inhibitors
- Patent number 12,030,884
- Issue date Jul 9, 2024
- Incyte Corporation
- Wenyu Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,999,740
- Issue date Jun 4, 2024
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vinyl imidazole compounds as inhibitors of KRAS
- Patent number 11,999,752
- Issue date Jun 4, 2024
- Incyte Corporation
- Peter Carlsen
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic amines as CDK2 inhibitors
- Patent number 11,976,073
- Issue date May 7, 2024
- Incyte Corporation
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Quinoline compounds as inhibitors of KRAS
- Patent number 11,939,328
- Issue date Mar 26, 2024
- Incyte Corporation
- Qinda Ye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
- Patent number 11,884,665
- Issue date Jan 30, 2024
- Incyte Corporation
- Taisheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrimidine derivatives as A2A/A2B inhibitors
- Patent number 11,873,304
- Issue date Jan 16, 2024
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Bicyclic dione compounds as inhibitors of KRAS
- Patent number 11,767,320
- Issue date Sep 26, 2023
- Incyte Corporation
- Taisheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrimidine compounds as KRAS inhibitors
- Patent number 11,739,102
- Issue date Aug 29, 2023
- Incyte Corporation
- Gia Hoang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors
- Patent number 11,673,894
- Issue date Jun 13, 2023
- Incyte Corporation
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrrolotriazine compounds as TAM inhibitors
- Patent number 11,591,338
- Issue date Feb 28, 2023
- Incyte Corporation
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Spiro compounds as inhibitors of KRAS
- Patent number 11,530,218
- Issue date Dec 20, 2022
- Incyte Corporation
- Le Zhao
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors
- Patent number 11,390,624
- Issue date Jul 19, 2022
- Incyte Corporation
- Taisheng Huang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 11,247,992
- Issue date Feb 15, 2022
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrole tricyclic compounds as A2A / A2B inhibitors
- Patent number 11,220,510
- Issue date Jan 11, 2022
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrimidine derivatives as A2A / A2B inhibitors
- Patent number 11,168,089
- Issue date Nov 9, 2021
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fused pyrazine derivatives as A2A / A2B inhibitors
- Patent number 11,161,850
- Issue date Nov 2, 2021
- Incyte Corporation
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidine derivatives as TAM inhibitors
- Patent number 11,136,326
- Issue date Oct 5, 2021
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors
- Patent number 10,968,221
- Issue date Apr 6, 2021
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine compounds as TAM inhibitors
- Patent number 10,844,069
- Issue date Nov 24, 2020
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and uses thereof
- Patent number 10,723,705
- Issue date Jul 28, 2020
- Incyte Corporation
- Jun Pan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors
- Patent number 10,556,908
- Issue date Feb 11, 2020
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolopyrimidine derivatives as TAM inhibitors
- Patent number 10,519,163
- Issue date Dec 31, 2019
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Pyrrolotriazine compounds as TAM inhibitors
- Patent number 10,442,810
- Issue date Oct 15, 2019
- Incyte Corporation
- Yun-Long Li
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,300,051
- Issue date May 28, 2019
- Incyte Corporation
- Liangxing Wu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Cyclopropylamines as LSD1 inhibitors
- Patent number 10,174,030
- Issue date Jan 8, 2019
- Incyte Corporation
- Liangxing Wu
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS
- Publication number 20250206734
- Publication date Jun 26, 2025
- INCYTE CORPORATION
- Dipendu Das
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLOOCTANE KRAS INHIBITORS
- Publication number 20250195536
- Publication date Jun 19, 2025
- INCYTE CORPORATION
- Yannik Boni
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY COMPRISING DGK INHIBITORS and PD-1/PD-L1 INHIBI...
- Publication number 20250186450
- Publication date Jun 12, 2025
- INCYTE CORPORATION
- Xiaodi Ren
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20250188073
- Publication date Jun 12, 2025
- INCYTE CORPORATION
- Xiaozhao Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS
- Publication number 20250179083
- Publication date Jun 5, 2025
- INCYTE CORPORATION
- Joshua Hummel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
KRAS INHIBITORS
- Publication number 20250163079
- Publication date May 22, 2025
- INCYTE CORPORATION
- Taisheng Huang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SPIROCYCLIC LACTAM INHIBITORS
- Publication number 20250101020
- Publication date Mar 27, 2025
- INCYTE CORPORATION
- Stacey Shepard
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS
- Publication number 20250084063
- Publication date Mar 13, 2025
- INCYTE CORPORATION
- Oleg Vechorkin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS
- Publication number 20250084087
- Publication date Mar 13, 2025
- INCYTE CORPORATION
- Oleg Vechorkin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Bicyclic DGK Inhibitors
- Publication number 20250066363
- Publication date Feb 27, 2025
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...
- Publication number 20250059293
- Publication date Feb 20, 2025
- INCYTE CORPORATION
- Horacio G. Nastri
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors
- Publication number 20250041310
- Publication date Feb 6, 2025
- INCYTE CORPORATION
- Hui Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS
- Publication number 20250034153
- Publication date Jan 30, 2025
- INCYTE CORPORATION
- Heeoon Han
- C07 - ORGANIC CHEMISTRY
Information Patent Application
BICYCLIC AMINES AS CDK2 INHIBITORS
- Publication number 20240415840
- Publication date Dec 19, 2024
- INCYTE CORPORATION
- Joshua Hummel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PYRAZOLOQUINOLINE KRAS INHIBITORS
- Publication number 20240400557
- Publication date Dec 5, 2024
- INCYTE CORPORATION
- Wenyu ZHU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLIDINE KRAS INHIBITORS
- Publication number 20240390340
- Publication date Nov 28, 2024
- INCYTE CORPORATION
- Onur ATASOYLU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20240368152
- Publication date Nov 7, 2024
- INCYTE CORPORATION
- Qinda YE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
2-AZABICYCLO[2.2.1]HEPTANE KRAS INHIBITORS
- Publication number 20240368156
- Publication date Nov 7, 2024
- INCYTE CORPORATION
- Onur ATASOYLU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CYCLIC UREA KRAS INHIBITORS
- Publication number 20240358702
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Onur ATASOYLU
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS
- Publication number 20240360140
- Publication date Oct 31, 2024
- INCYTE CORPORATION
- Xiaozhao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS
- Publication number 20240343742
- Publication date Oct 17, 2024
- INCYTE CORPORATION
- Peter Carlsen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Bicyclic Ureas As Kinase Inhibitors
- Publication number 20240317744
- Publication date Sep 26, 2024
- INCYTE CORPORATION
- Xin Li
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heteroaryl Fluoroalkenes As DGK Inhibitors
- Publication number 20240270739
- Publication date Aug 15, 2024
- INCYTE CORPORATION
- Ming Xiang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Heteroaryl Fluoroalkenes As DGK Inhibitors
- Publication number 20240217989
- Publication date Jul 4, 2024
- INCYTE CORPORATION
- Ming Xiang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS
- Publication number 20240124463
- Publication date Apr 18, 2024
- INCYTE CORPORATION
- Yun-Long Li
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS
- Publication number 20240101557
- Publication date Mar 28, 2024
- INCYTE CORPORATION
- GENCHENG LI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS
- Publication number 20240083898
- Publication date Mar 14, 2024
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRACYCLIC COMPOUNDS AS DGK INHIBITORS
- Publication number 20240034734
- Publication date Feb 1, 2024
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TETRACYCLIC COMPOUNDS AS DGK INHIBITORS
- Publication number 20240025900
- Publication date Jan 25, 2024
- Incyte Corporation
- Joshua Hummel
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS
- Publication number 20230399342
- Publication date Dec 14, 2023
- INCYTE CORPORATION
- Joshua Hummel
- C07 - ORGANIC CHEMISTRY

Xiaozhao Wang

Person

Patents Grantslast 30 patents

Hetero-bicyclic inhibitors of KRAS

Imidazole and triazole KRAS inhibitors

CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination...

Hetero-tricyclic compounds as inhibitors of KRAS

Pyrazoloquinoline KRAS inhibitors

Fused pyrazine derivatives as A2A / A2B inhibitors

Vinyl imidazole compounds as inhibitors of KRAS

Bicyclic amines as CDK2 inhibitors

Quinoline compounds as inhibitors of KRAS

Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Fused pyrimidine derivatives as A2A/A2B inhibitors

Bicyclic dione compounds as inhibitors of KRAS

Fused pyrimidine compounds as KRAS inhibitors

Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Spiro compounds as inhibitors of KRAS

Pyrazolopyridines and triazolopyridines as A2A / A2B inhibitors

Cyclopropylamines as LSD1 inhibitors

Pyrrole tricyclic compounds as A2A / A2B inhibitors

Fused pyrimidine derivatives as A2A / A2B inhibitors

Fused pyrazine derivatives as A2A / A2B inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Substituted [1,2,4]triazolo[1,5-a]pyrazines as LSD1 inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Heterocyclic compounds and uses thereof

Substituted imidazo[1,2-a]pyrazines as LSD1 inhibitors

Pyrrolopyrimidine derivatives as TAM inhibitors

Pyrrolotriazine compounds as TAM inhibitors

Cyclopropylamines as LSD1 inhibitors

Cyclopropylamines as LSD1 inhibitors

Patents Applicationslast 30 patents

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

BICYCLOOCTANE KRAS INHIBITORS

COMBINATION THERAPY COMPRISING DGK INHIBITORS and PD-1/PD-L1 INHIBI...

TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS

TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS

KRAS INHIBITORS

SPIROCYCLIC LACTAM INHIBITORS

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

BICYCLIC HETEROCYCLES AS MRGPRX2 ANTAGONISTS

Bicyclic DGK Inhibitors

CD73 INHIBITOR AND A2A/A2B ADENOSINE RECEPTOR INHIBITOR COMBINATION...

Combination Therapy Comprising A2A/A2B and PD-1/PD-L1 Inhibitors

TRIAZOLOPYRIMIDINES AS A2A / A2B INHIBITORS

BICYCLIC AMINES AS CDK2 INHIBITORS

PYRAZOLOQUINOLINE KRAS INHIBITORS

PYRROLIDINE KRAS INHIBITORS

QUINOLINE COMPOUNDS AS INHIBITORS OF KRAS

2-AZABICYCLO[2.2.1]HEPTANE KRAS INHIBITORS

CYCLIC UREA KRAS INHIBITORS

FUSED PYRAZINE DERIVATIVES AS A2A / A2B INHIBITORS

VINYL IMIDAZOLE COMPOUNDS AS INHIBITORS OF KRAS

Bicyclic Ureas As Kinase Inhibitors

Heteroaryl Fluoroalkenes As DGK Inhibitors

Heteroaryl Fluoroalkenes As DGK Inhibitors

PYRROLOTRIAZINE COMPOUNDS AS TAM INHIBITORS

FUSED TRICYCLIC COMPOUNDS AS INHIBITORS OF KRAS G12V MUTANTS

TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS

TETRACYCLIC COMPOUNDS AS DGK INHIBITORS

TETRACYCLIC COMPOUNDS AS DGK INHIBITORS

TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS